GenoMed Inc. (GMED)

[mingwan0]

According to the last 10Q:

http://12.40.163.150/Archives/edgar/data/1169417/000118206303000278/gm10qsb.htm

There were 1 billion shares authorized and 123,235,065 shares issued and outstanding. In March ADOT purchased just over 33 million shares of restricted common stock for $900,000 (this representing some 21% of the common stock).

From the 10Q you can see in Part II (Other Information), Item 2 (Changes in Securities and Use of Proceeds) the limited issuance of shares that has occured in relation to services provided by consultants, and the existing funding agreement with Research Capital.

There is no history of excessive dilution and no indication that there will be such dilution in the foreseeable future.